the evolution of treatment patterns and prognostic biomarkers in latin american cll patients
Published 1 year ago • 48 plays • Length 3:03Download video MP4
Download video MP3
Similar videos
-
6:17
the progression and evolution of cll: mechanisms and therapies
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
1:31
how the treatment and management of all changes with age
-
0:45
key trials in cll and designing a concept for treatment
-
3:15
what is leukemia?
-
5:10
why do our bodies age? - monica menesini
-
13:20
chapter 1: the evolving virus
-
2:19
disease staging systems in multiple myeloma and how these have evolved over the years
-
4:25
cll: state of the art in italy
-
2:50
new cll treatments, the standard of care and the importance of clonal evolution
-
6:07
treatment patterns and outcomes of older hl patients from the brazilian prospective hl registry
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
4:31
labmt: impact of treatment prior to allogenic hct in mds
-
2:47
clinical and prognostic implications of wt1 mutations in de novo and r/r aml
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
4:20
therapy-related all: etiology, prognosis, and treatment
-
2:45
an insight into clinical risk factors for progression in mpns
-
2:13
limitations of prognostic staging systems for multiple myeloma
-
1:35
55-month follow-up from glow: fixed-duration ibr ven vs clb o in treatment naïve cll
-
2:09
heart transplantation in attr amyloidosis